ADVOCACY FOR IMPACT
Live / Registered — Registered (as of 28 Dec 2021)
What this means for you
Registered since 28 Dec 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88126473
- Registration number
- 6603392
- Mark type
- Stylized text
- Filed
- 21 Sept 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 28 Dec 2021
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 036 — Insurance and financial services: Providing grants to patient advocacy groups in support of projects that will have an effect on rare diseases; conducting a competitive grants program, namely, providing grants for patient advocacy groups; charitable services, namely, granting funds to support projects directed to rare diseases
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 30 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Dec 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Nov 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Nov 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Oct 2021 — USE AMENDMENT FILED
- 29 Oct 2021 — SOU EXTENSION 5 GRANTED
- 22 Oct 2021 — SOU EXTENSION 5 FILED
- 29 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 13 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 24 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED